Families in southern New England will now have expanded access to endocrinology, cardiometabolic health, psychiatry, neurology, and general medicine clinical trials. John Stoukides, MD, and Daniel Sacchetti, DO, principal investigators and physicians with deep roots in the medical community, along with William Menard, Managing Partner, will be part of the leadership team of the new clinic.
The new clinic is a state-of-the-art facility that spans 7,000 square feet. It features a pharmacy, on site laboratory, and infusion suite.
Dr. Sacchetti said that this is an exciting milestone as:
“..this new clinical research site [is] dedicated to advancing innovation in neuroscience and cardiometabolic health in Foxboro.”
He expressed his pride in helping to build a center where contributions can be made to the development of therapies for the future while at the same time cutting-edge clinical trials can be accessed by patients. He added that he is looking forward to accelerating discoveries that improve the quality of life and outcomes for individuals affected by cardiometabolic and neurologic disease.
The K2 team actively engages in the community through partnerships with local primary care providers, clinics, assisted living facilities, and community centers and participate in health fairs and cultural events and offer free educational seminars to local organizations.
Such new clinics and their services and contributions to the community can be promoted throughout a community with poster printing.